FY23 KCRP Nurse-Initiated Research Award Funding Opportunity

Strategic Insights -

The U.S. Department of Defense, Assistive Technology Research and Applications Agency (AMRAA) has issued a grants notice, titled "DoD Kidney Cancer, Nurse Initiated Research Award", which aims to fund innovative, high-impact kidney cancer research conducted by nurses working in clinical practice and/or an academic environment. The FY23 KCRP Nurse-Initiated Research Award supports projects that advance ideas or clinical care in kidney cancer, ideally in a multi-disciplinary manner led by a nurse.

Key Takeaways:

  • The award has an expected direct costs budget of $300,000, with an anticipated allotment of approximately $0.48M to fund one application.
  • The research focus areas include assessing access to care, health equity/health disparities, communication/patient education, quality of life, and patient support systems.
  • The award encourages applicants to leverage existing infrastructure, such as the Kidney Cancer Research Consortium (KCRC), to advance cancer research significant to the Warfighter, military families, and the American public.
  • The Nurse-Initiated Research Award will not directly support intervention clinical trial costs, but correlative studies and other research projects that run in parallel to a clinical trial are permissible.
  • Research involving human data, human anatomical substances, human subjects, or human cadavers must be reviewed and approved by the USAMRDC Office of Human and Animal Research Oversight (OHARO).
  • A clinical trial is defined as a research study in which one or more human subjects are prospectively assigned to one or more interventions, and the award will not directly support intervention clinical trial costs.

Statistics:

  • The award has an expected direct costs budget of $300,000.
  • The anticipated allotment is approximately $0.48M to fund one application.
  • The award expects to be funded with FY23 funds, which expire for use on September 30, 2029.
  • Research with human data, human anatomical substances, human subjects, or human cadavers must be reviewed and approved by the USAMRDC OHARO within 3 months.
  • A single IRB must review and approve the portion of the research conducted at domestic sites in accordance with Code of Federal Regulations, Title 45, Part 46.114(b).

Sources:

  • U.S. Department of Defense, AMRAA (June 10)
  • U.S. Department of Veterans Affairs (VA) Resources
  • 31 USC 6304
  • 31 USC 6305
  • Title 45, Part 46.114(b)